Lederman Seth bought 5,000 shares of Tonix Pharmaceuticals Holding Corp. at $4.06 for $20.3k on Nov 11, 2026

Buy
Form 4 code P. Open-market or private purchase of a non-derivative or derivative security.
Chief Executive Officer
Chief Executive Officer
Filed Nov 12, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
$20,275Shares × reported price
Shares traded
5,000Common Stock, $0.001 par value
Price per share
$4.06Reported price. Read footnotes for ranges.
% of reported position traded
45.43%This security and ownership context
Holdings after
16,005Direct
Trade date
Nov 11, 2026Buy
Filed
Nov 12, 2026, 8:00 AM ET1-day reporting delay
Accession
0001493152-26-051200Code P · Transaction 398225
How reported position traded is calculated

Shares purchased ÷ (holdings after − shares purchased). Estimated position before: 11,005 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

TNXP price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
TNXP · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 19, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago +23%1w ago 0%1d ago 0%
Returns since7d30d90d180d1y

Footnotes in full

F1: Reporting person may be deemed a control person of this entity.